Physician profile
John Eliades
NPI 1801861844
$817.68
in general payments reported to CMS, 2019-2025
10 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.50 · 2020: $12.88 · 2022: $70.65 · 2023: $36.21 · 2024: $397 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $325.32 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $148.19 | 2022-2024 | Nushield |
| Smith+Nephew, INC. | $122.01 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Avita Medical Americas, LLC | $58.92 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Convatec INC. | $38.81 | 2023-2025 | |
| Solventum Corporation | $32.84 | 2024 | Activ.A.C., 3m Coban, Kerramax Care |
| Mimedx Group, INC. | $27.27 | 2024 | |
| Tactile Systems Technology INC | $24.47 | 2019-2020 | |
| Urgo Medical North America, LLC | $20.42 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Reprise Biomedical, INC. | $19.43 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eliades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.